Drug precursors are indispensable in various industries like pharmaceuticals, cosmetics, fertilisers or plastics. However, they can be diverted by criminals for the illicit production of drugs such as amphetamines, ecstasy, methamphetamine, cocaine, and heroin.

The trade of drug precursors is already strictly monitored and controlled at the international, EU, and Member State levels, to prevent drug producers from getting their hands on such drug precursors. However, criminal networks increasingly circumvent existing controls by turning to designer precursors, substances with no known legitimate use (except innovation and research). This presents new challenges for the authorities in the EU.

The Commission proposal introduces measures for faster and effective monitoring and control, significantly curbing drug- and designer precursors' availability for illegal drug manufacturing. At the same time, the initiative will simplify processes for legitimate drug precursor trade, ensuring chemical industries can thrive without excessive regulatory burdens.